SEC Form 4 · accession 0000899243-19-006335
GW PHARMACEUTICALS PLC · GWPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christopher J. Tovey
Officer — Chief Operating Officer
Period of report
Mar 1, 2019
Accepted (ET)
Mar 5, 2019 · 9:07 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001351288
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionsF1,F2,F3 | $14.33 | Mar 1, 2019 | A | 42,048 | A | Mar 1, 2022 | Mar 1, 2029 | Ordinary Shares | 42,048 | 42,048 | D |
| Stock OptionsF1,F4 | $0.0013 | Mar 1, 2019 | A | 79,812 | A | Mar 1, 2022 | Mar 1, 2029 | Ordinary Shares | 79,812 | 79,812 | D |
| Stock OptionsF1,F4 | $0.0013 | Mar 1, 2019 | A | 5,988 | A | Mar 1, 2020 | Mar 1, 2029 | Ordinary Shares | 5,988 | 5,988 | D |
| Stock OptionsF1,F4 | $0.0013 | Mar 1, 2019 | A | 5,988 | A | Mar 1, 2021 | Mar 1, 2029 | Ordinary Shares | 5,988 | 5,988 | D |
| Stock OptionsF1,F4 | $0.0013 | Mar 1, 2019 | A | 5,988 | A | Mar 1, 2022 | Mar 1, 2029 | Ordinary Shares | 5,988 | 5,988 | D |
| Stock OptionsF1,F4 | $0.0013 | Mar 1, 2019 | A | 5,988 | A | Mar 1, 2023 | Mar 1, 2029 | Ordinary Shares | 5,988 | 5,988 | D |
Explanation of responses
- F1Granted pursuant to the Issuer's Long-Term Incentive Plan.
- F2The reported options are options to purchase American Depositary Shares of the Issuer ("ADS"). Each ADS represents twelve ordinary shares of the Issuer.
- F3The exercise price reported is price per ordinary share converted from price per ADS ($172.01).
- F4Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.32 U.S. Dollars as of March 1, 2019.